Athenahealth Gets a Hold Rating from Jefferies

By Austin Angelo

Jefferies analyst John Difucci reiterated a Hold rating on Athenahealth (NASDAQ: ATHN) on June 23 and set a price target of $135. The company’s shares opened today at $145.88, close to its 52-week high of $149.55.

According to, Difucci is a top 25 analyst with an average return of 19.0% and a 76.4% success rate. Difucci covers the Technology sector, focusing on stocks such as SS&C Technologies Holdings, CommVault Systems, and AVG Technologies.

Currently, the analyst consensus on Athenahealth is Moderate Buy and the average price target is $134.82, representing a -7.6% downside.

In a report issued on June 13, Cantor Fitzgerald also downgraded the stock to Hold with a $140 price target.

The company has a one year high of $149.55 and a one year low of $90.11. Currently, Athenahealth has an average volume of 685.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

athenahealth, Inc. provides cloud-based business services and mobile applications for medical groups and health systems. It also provides ongoing billing, clinical-related, and other related services to customers. The company offers practice management and electronic health record services.